8th Diabetes Drug Discovery and Development

[liane]

www.gtcbio.com/conferences/diabetes-drug-discovery-development-agenda

8th Diabetes Drug Discovery and Development
April 27 - 29, 2015 Boston, MA


FEATURED SPEAKER
Andrea Leone-Bay
VP Scientific Research
MannKind
Tuesday April 28 11:05

Dry Powder Formulations for the Inhalation of Oxyntomodulin
leone bay andrea drug discovery Andrea Leone-Bay
VP Scientific Research
MannKind


Obesity is a rapidly becoming a global epidemic and underlies many disease conditions including diabetes and cardiovascular disease. Current treatment options are limited and are challenged by undesirable side effects. Oxyntomodulin (OXY) is an endogenous peptide hormone that signals satiety in healthy individuals. High circulating OXY concentrations are associated with satiety and low OXY concentrations are associated with a feeling of hunger. This activity profile positions OXY as a potential treatment for obesity. To address this unmet medical need, this presentation will introduce an approach to developing an orally inhaled dry powder OXY product administered using a small, breath-powered inhaler for obesity therapy.

The audience will learn about oxyntomodulin, a potential new obesity therapy and about the administration of peptides by oral inhalation using a simple, patient-friendly approach.

[diabetesbetter]

Thanks for the info. Never know about Oxyntomodulin before...sound like it works good.

[dg1111]

Also speaking at the same conference, with what seems like a very similar topic:

1:50 Targeting Diabetes Care through Weight Management


larsen philip drug discovery Philip Larsen
Vice President
Sanofi

[notamnkdmillionaire]

Inhalable Oxycodone? WOO HOO! Oh, my bad. It's not that type of Oxy.

Kidding aside, is this the next target for Mannkind? Me thinks it is. And yet another HUGE market if inhaling oxy can safely help people lose weight.